Syncona’s Nightstar Therapeutics to be bought by Biogen for $877 million
Nightstar Therapeutics has agreed to be acquired by Biogen.
Read More
Tag: Nightstar Therapeutics
- NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats
- UCB reports superiority of bimekizumab in psoriatic arthritis study
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
